Joaquim José Coutinho Ferreira
AuthID: R-000-7JF
291
TITLE: Opicapone for the management of end-of-dose motor fluctuations in patients with Parkinson's disease treated with L-DOPA
AUTHORS: Lees, AJ; Ferreira, J; Rascol, O; Reichmann, H; Stocchi, F; Tolosa, E; Poewe, W;
PUBLISHED: 2017, SOURCE: EXPERT REVIEW OF NEUROTHERAPEUTICS, VOLUME: 17, ISSUE: 7
AUTHORS: Lees, AJ; Ferreira, J; Rascol, O; Reichmann, H; Stocchi, F; Tolosa, E; Poewe, W;
PUBLISHED: 2017, SOURCE: EXPERT REVIEW OF NEUROTHERAPEUTICS, VOLUME: 17, ISSUE: 7
292
TITLE: PLACEBO AND NOCEBO RESPONSES IN RLS: A META-ANALYSIS
AUTHORS: Rodrigues, FB; Duarte, GS; Silva, MA; Fernandes, RM; Abreu, D; Mestre, T; Costa, J; Trenkwalder, C; Ferreira, JJ;
PUBLISHED: 2017, SOURCE: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, VOLUME: 88, ISSUE: Suppl 1
AUTHORS: Rodrigues, FB; Duarte, GS; Silva, MA; Fernandes, RM; Abreu, D; Mestre, T; Costa, J; Trenkwalder, C; Ferreira, JJ;
PUBLISHED: 2017, SOURCE: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, VOLUME: 88, ISSUE: Suppl 1
293
TITLE: Substantia Nigra Neuromelanin as an Imaging Biomarker of Disease Progression in Parkinson's Disease
AUTHORS: Fabbri, M; Reimao, S; Carvalho, M; Nunes, RG; Abreu, D; Guedes, LC; Bouça, R; Lobo, PP; Godinho, C; Coelho, M; Gonçalves, NC; Rosa, MM; Antonini, A; Ferreira, JJ;
PUBLISHED: 2017, SOURCE: JOURNAL OF PARKINSONS DISEASE, VOLUME: 7, ISSUE: 3
AUTHORS: Fabbri, M; Reimao, S; Carvalho, M; Nunes, RG; Abreu, D; Guedes, LC; Bouça, R; Lobo, PP; Godinho, C; Coelho, M; Gonçalves, NC; Rosa, MM; Antonini, A; Ferreira, JJ;
PUBLISHED: 2017, SOURCE: JOURNAL OF PARKINSONS DISEASE, VOLUME: 7, ISSUE: 3
294
TITLE: The era of the novel oral anticoagulants in Portugal
AUTHORS: Caldeira, D; Ferreira, JJ; Pinto, FJ;
PUBLISHED: 2017, SOURCE: REVISTA PORTUGUESA DE CARDIOLOGIA, VOLUME: 36, ISSUE: 7-8
AUTHORS: Caldeira, D; Ferreira, JJ; Pinto, FJ;
PUBLISHED: 2017, SOURCE: REVISTA PORTUGUESA DE CARDIOLOGIA, VOLUME: 36, ISSUE: 7-8
INDEXED IN: 
WOS
WOS IN MY: 
ORCID
ORCID295
TITLE: Occupational pesticide exposure and penetrance of LRRK2 Parkinson's disease (PD) Full Text
AUTHORS: Tanner, C; Marras, C; Marder, K; Bressman, S; Alcalay, R; Saunders Pullman, R; Meng, CC; Gold Man, S; Korell, M; Luciano, MS; Tolosa, E; Schuele, B; Langston, JW; Brice, A; Mellick, G; Ferreira, J; Tazir, M; Klein, C; Berg, D; Lang, A;
PUBLISHED: 2017, SOURCE: MOVEMENT DISORDERS, VOLUME: 32
AUTHORS: Tanner, C; Marras, C; Marder, K; Bressman, S; Alcalay, R; Saunders Pullman, R; Meng, CC; Gold Man, S; Korell, M; Luciano, MS; Tolosa, E; Schuele, B; Langston, JW; Brice, A; Mellick, G; Ferreira, J; Tazir, M; Klein, C; Berg, D; Lang, A;
PUBLISHED: 2017, SOURCE: MOVEMENT DISORDERS, VOLUME: 32
INDEXED IN: WOS
WOS IN MY: ORCID
ORCID296
TITLE: Response of non-motor symptoms to levodopa in late-stage Parkinson's disease: Results of a levodopa challenge test Full Text
AUTHORS: Fabbri, M; Coelho, M; Guedes, LC; Chendo, I; Sousa, C; Rosa, MM; Abreu, D; Costa, N; Godinho, C; Antonini, A; Ferreira, JJ;
PUBLISHED: 2017, SOURCE: PARKINSONISM & RELATED DISORDERS, VOLUME: 39
AUTHORS: Fabbri, M; Coelho, M; Guedes, LC; Chendo, I; Sousa, C; Rosa, MM; Abreu, D; Costa, N; Godinho, C; Antonini, A; Ferreira, JJ;
PUBLISHED: 2017, SOURCE: PARKINSONISM & RELATED DISORDERS, VOLUME: 39
INDEXED IN: WOS
WOS IN MY: ORCID
ORCID297
TITLE: Fifteen Years of Clinical Trials in Huntington's Disease: A Very Low Clinical Drug Development Success Rate
AUTHORS: Travessaa, AM; Rodrigues, FB; Mestre, TA; Ferreira, JJ;
PUBLISHED: 2017, SOURCE: JOURNAL OF HUNTINGTONS DISEASE, VOLUME: 6, ISSUE: 2
AUTHORS: Travessaa, AM; Rodrigues, FB; Mestre, TA; Ferreira, JJ;
PUBLISHED: 2017, SOURCE: JOURNAL OF HUNTINGTONS DISEASE, VOLUME: 6, ISSUE: 2
INDEXED IN: WOS
WOS IN MY: ORCID
ORCID298
TITLE: Gene Expression Differences in Peripheral Blood of Parkinson's Disease Patients with Distinct Progression Profiles (vol 11, e157852, 2016) Full Text
AUTHORS: Pinho, R; Guedes, LC; Soreq, L; Lobo, PP; Mestre, T; Coelho, M; Rosa, MM; Gonçalves, N; Wales, P; Mendes, T; Gerhardt, E; Fahlbusch, C; Bonifati, V; Bonin, M; Miltenberger Miltényi, G; Borovecki, F; Soreq, H; Ferreira, JJ; Outeiro, TF;
PUBLISHED: 2017, SOURCE: PLOS ONE, VOLUME: 12, ISSUE: 12
AUTHORS: Pinho, R; Guedes, LC; Soreq, L; Lobo, PP; Mestre, T; Coelho, M; Rosa, MM; Gonçalves, N; Wales, P; Mendes, T; Gerhardt, E; Fahlbusch, C; Bonifati, V; Bonin, M; Miltenberger Miltényi, G; Borovecki, F; Soreq, H; Ferreira, JJ; Outeiro, TF;
PUBLISHED: 2017, SOURCE: PLOS ONE, VOLUME: 12, ISSUE: 12
INDEXED IN: WOS
WOS IN MY: ORCID
ORCID299
TITLE: Neutralizing Antibody and Botulinum Toxin Therapy: A Systematic Review and Meta-analysis Full Text
AUTHORS: Margherita Fabbri; Giorgio Leodori; Ricardo M Fernandes; Roongroj Bhidayasiri; Maria J Jose Marti; Carlo Colosimo; Joaquim J Ferreira;
PUBLISHED: 2016, SOURCE: NEUROTOXICITY RESEARCH, VOLUME: 29, ISSUE: 1
AUTHORS: Margherita Fabbri; Giorgio Leodori; Ricardo M Fernandes; Roongroj Bhidayasiri; Maria J Jose Marti; Carlo Colosimo; Joaquim J Ferreira;
PUBLISHED: 2016, SOURCE: NEUROTOXICITY RESEARCH, VOLUME: 29, ISSUE: 1
300
TITLE: Bridging Anticoagulation in Patients with Atrial Fibrillation
AUTHORS: Daniel Caldeira; Joao Costa; Joaquim J Ferreira;
PUBLISHED: 2016, SOURCE: NEW ENGLAND JOURNAL OF MEDICINE, VOLUME: 374, ISSUE: 1
AUTHORS: Daniel Caldeira; Joao Costa; Joaquim J Ferreira;
PUBLISHED: 2016, SOURCE: NEW ENGLAND JOURNAL OF MEDICINE, VOLUME: 374, ISSUE: 1
INDEXED IN: WOS
WOS IN MY: ORCID
ORCID